Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Kite Pharma, Inc. (KITE)

« Back to company index

KITE Chatter Timeline

Stock Ticker for KITE

Most Active Tweeters for KITE

No tweets found

Recent Tweets for KITE

MaxPowerNGS @MaxPowerNGS
@adamfeuerstein @sxbegle $KITE “focused on developing and refining our T Cell co-stumulatory domains” This is being… https://t.co/tZvxDdKjYp
August 21st 2018, 7:08pm
rb01234 @rb01234
@AlpineBV_Miller David, you collaborated with $kite in the past? I imagine you have specific abilities and ideas for the future...
August 21st 2018, 6:08pm
MichelDoepke @MichelDoepke
$GILD still under pressure after $KITE acquisition. New targets on the horizon after CMO resignation? #NASH space?… https://t.co/KhpUZN16EY
August 15th 2018, 4:08pm
m_denniswinters @m_denniswinters
@OptionsHawk Reminds me of $celg and $kite
August 6th 2018, 6:08am
edchiesa26 @edchiesa26
@omg_keynes Instead, $GILD decided to ‘go fly a $KITE.’
August 6th 2018, 12:08am
Slambucket @Slambucket
@marcfrontario @surveyist $XCUR also has $KITE flavored BoD https://t.co/hTfL0OmNUO
August 1st 2018, 5:08pm
JacobPlieth @JacobPlieth
Gregg Sando out as CEO of Cell Medica. Replaced by Chris Nowers (ex $KITE ) https://t.co/ErQUkBAPkB
August 1st 2018, 4:08am
ChartMill @ChartMill
$KITE has an excellent technical rating and also presents a decent setup pattern. https://t.co/aiMLDytOky https://t.co/cYdA3ruM74
July 30th 2018, 4:07pm
dhovekamp42 @dhovekamp42
@BehaviorFin @marcfrontario That is what the CEO seems to suggest with his ugly slide pointing to $JUNO and $KITE b… https://t.co/oNBOtzKdVe
July 26th 2018, 4:07am
tstamm7002 @tstamm7002
Any $GILD officers left since the $KITE b/o? 100% turnover
July 25th 2018, 4:07pm
zbiotech @zbiotech
@adamfeuerstein and they won't be around to see how well that $KITE deal turns out...
July 25th 2018, 4:07pm
AlpBugraBasat @AlpBugraBasat
@JosephRamelli See $KITE and $ONCE on the other side and decide yourself.
July 23rd 2018, 8:07pm
BursatilBiotech @BursatilBiotech
@bradloncar They have been acquired but I guess both , $KITE & $JUNO, can be on that list.
July 23rd 2018, 4:07pm
Biotech_Beast @Biotech_Beast
@Sanctuary_Bio @AndyBiotech Perhaps that is when it came onto your radar because of $KITE IPO for example. Even if… https://t.co/YgWd7xAULC
July 18th 2018, 10:07am
eastvillagetwt @eastvillagetwt
Leading Commercial and Transactional Healthcare Executive Shawn Cline Tomasello Joins Mesoblast Board $MESO $KITE https://t.co/Lft8OGcqb9
July 16th 2018, 4:07pm
MaxSpeculation @MaxSpeculation
$SGMO i bet he’s going to that startup with former $KITE ceo, the same one who stole Eric Schmidt at Cowen.
July 13th 2018, 6:07pm
ChartMill @ChartMill
Don't miss the breakout on $KITE. Buy stop @179.83, stop loss @179.07 is suggested by the ChartMill analyzer..… https://t.co/GVZfXHOwXp
July 9th 2018, 9:07pm
alan_hollen @alan_hollen
@hieuvnguyen Perma bear bot here. Danger. Bear on $kite all the way to $175
June 27th 2018, 10:06am
sesiegler @sesiegler
RT @sesiegler: I cannot believe that this is actually online! $KITE @VinayPrasad82 https://t.co/U9cMj7xEMf https://t.co/uWrINHAdHD
June 26th 2018, 8:06am
Just_Xu_It @Just_Xu_It
@Lblegend33 True, at least this year has been a step up from last year. However, it’d be nice to see another big acquisition like $KITE.
June 25th 2018, 9:06pm
RCR52 @RCR52
@Allstocknews This is $KITE twin, FDA will approve them early and they will be scooped up
June 18th 2018, 8:06am
datamonitor_JA @datamonitor_JA
RT @BursatilBiotech: $NVS released their 14-month results from JULIET's study aaaand I had to take $KITE's DoR too ( cc @datamonitor_JA )…
June 16th 2018, 4:06pm
BursatilBiotech @BursatilBiotech
$NVS released their 14-month results from JULIET's study aaaand I had to take $KITE's DoR too ( cc @datamonitor_JA… https://t.co/RLKeOORhfX
June 16th 2018, 3:06pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
@BursatilBiotech $KITE is a $SGMO sub now
June 12th 2018, 4:06pm
imriyu @imriyu
@zbiotech @adamfeuerstein I know it will come... Israel is not a banana repoblick. Shame on you. $KITE
June 12th 2018, 9:06am
robertinsydney @robertinsydney
@bradloncar Glad I sold $kite at $179!
June 11th 2018, 2:06pm
stb8444 @stb8444
Based on what I’ve been watching for years in biotech, funds pick winners early and ride them, $kite winner, $juno… https://t.co/d2qEiaL7H9
June 9th 2018, 7:06pm
RCR52 @RCR52
@ShaaRedNL This company is a replica of $KITE after the solid Success of their Phase 3 Car T FDA early approval is imminent
June 8th 2018, 10:06pm
Just_Xu_It @Just_Xu_It
@hieuvnguyen Not exactly the case -> $KITE acquisition by $GILD
June 8th 2018, 10:06am
AlpBugraBasat @AlpBugraBasat
Of note, this technology has been licensed to $GILD subsidiary $KITE. Breast cancer market can probably provide som… https://t.co/ITKiBDRvG9
June 5th 2018, 4:06pm
robertinsydney @robertinsydney
@bradloncar Cld $AMZN (which I have owned for sometime) be another $KITE! https://t.co/BZ3fCy4WpR
June 5th 2018, 3:06pm
zbiotech @zbiotech
$GILD head of corp devt/strategy (who led $KITE and cell design labs) leaving end of aug
June 4th 2018, 5:06pm
elijahwc @elijahwc
$GILD $KITE Might just be a growth stock again. Stunning if true. https://t.co/lr5IyQhoBi
June 4th 2018, 11:06am
Saba_Capital @Saba_Capital
RT @RVH_Investing: $GILD $KITE ZUMA-3 DATA SUGGESTS HIGH COMPLETE RESPONSE RATE W/KTE-C19
June 4th 2018, 11:06am
RVH_Investing @RVH_Investing
$GILD $KITE ZUMA-3 DATA SUGGESTS HIGH COMPLETE RESPONSE RATE W/KTE-C19
June 4th 2018, 11:06am
RVH_Investing @RVH_Investing
$GILD $KITE: ZUMA-1 OF YESCARTA DATA MAY PREDICT L-T DISEASE CONTROL
June 4th 2018, 11:06am
StockTipRobot @StockTipRobot
I'm not a financial advisor, I'm a twitter robot. And that's why you should dump all of Kite Pharma $KITE #StockAdvice
June 3rd 2018, 4:06pm
OSmithBio @OSmithBio
Branding game is strong this year at #ASCO18 where big biotech’s are tapping into my favourite things $kite $gild… https://t.co/SVHhscFOfc
June 3rd 2018, 3:06pm
DrEnologist @DrEnologist
RT @BillKoski2: ZUMA-1 update: 79% of patients achieving CR maintain response at 12-month follow-up. $KITE $GILD #ASCO18
June 2nd 2018, 7:06pm
BillKoski2 @BillKoski2
ZUMA-1 update: 79% of patients achieving CR maintain response at 12-month follow-up. $KITE $GILD #ASCO18
June 2nd 2018, 5:06pm
DDRANTE @DDRANTE
RT @DDRANTE: Volume is insane 13,982% vs 46,000 Ave $TPIV non compare to $KITE #cancer #Biotech #Tcell https://t.co/olW5xGa7oP https://t.…
May 31st 2018, 12:05pm
DDRANTE @DDRANTE
Volume is insane 13,982% vs 46,000 Ave $TPIV non compare to $KITE #cancer #Biotech #Tcell https://t.co/olW5xGa7oP https://t.co/gcm5vCRejn
May 31st 2018, 10:05am
ChartMill @ChartMill
$KITE has a Quick Ratio of 9.01, indicating it is financially healthy. https://t.co/u90EUIH0mB https://t.co/ltkxAPuCbs
May 27th 2018, 6:05pm
DrTranBioSci @DrTranBioSci
TapImmune: Stellar Innovation To Deliver Hopes To Patients While Unlocking Value For Investors $TPIV $KITE https://t.co/43kSvR2hld
May 26th 2018, 9:05pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @MichelDoepke: $GILD the oncology company after HIV and HCV? Well positioned with acquisition of $KITE / Cell Design Labs and the amazin…
May 23rd 2018, 12:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.